4.6 Article

The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Defining mild cognitive impairment in Parkinson's disease

John N. Caviness et al.

MOVEMENT DISORDERS (2007)

Article Clinical Neurology

Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia

Carmen Cristea Janvin et al.

MOVEMENT DISORDERS (2006)

Article Clinical Neurology

Cognitive profile of patients with newly diagnosed Parkinson disease

D Muslimovic et al.

NEUROLOGY (2005)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Article Clinical Neurology

Assessment of cognition in Parkinson's disease

J Marinus et al.

NEUROLOGY (2003)

Article Clinical Neurology

Depressed mood and executive dysfunction in early Parkinson's disease

J Uekermann et al.

ACTA NEUROLOGICA SCANDINAVICA (2003)

Article Clinical Neurology

Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study

D Aarsland et al.

ARCHIVES OF NEUROLOGY (2003)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY